Literature DB >> 1843848

Testicular function in active ankylosing spondylitis. Therapeutic response to human chorionic gonadotrophin.

R Tapia-Serrano1, F J Jimenez-Balderas, S Murrieta, C Bravo-Gatica, R Guerra, G Mintz.   

Abstract

Testicular function was studied in 22 patients with ankylosing spondylitis (AS) with serum measurements of hormone levels, seminal fluid analysis and testicular reserve test. Results were correlated with disease activity. The abnormal findings were elevated luteinizing hormone (LH), inversion of estradiol/testosterone ratio (E2:T) and diminished testicular reserve for testosterone (T) and slightly increased for estradiol (E2). Nine patients with severe active AS received biweekly 2,500 IU of human chorionic gonadotrophin injections with a resulting increase in E2 serum levels. When the values of E2 reached 40 pg/ml or higher, there was a decrease of the sedimentation rate (p less than 0.05) and a reversal to normal of the E2:T ratio. This was accompanied by an improvement in AS at the 10th week that lasted up to 9 weeks after discontinuation of treatment. Our findings suggest a possible role of sex hormones in the physiopathogenesis of AS and offers a possible therapeutic alternative.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1843848

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  8 in total

1.  Bone turnover markers, anterior pituitary and gonadal hormones, and bone mass evaluation using quantitative computed tomography in ankylosing spondylitis.

Authors:  Abdellah El Maghraoui; Saida Tellal; Souad Chaouir; Khalil Lebbar; Ahmed Bezza; Abderrazak Nouijai; Lahsen Achemlal; Sanaa Bouhssain; El Mostapha Derouiche
Journal:  Clin Rheumatol       Date:  2004-12-08       Impact factor: 2.980

2.  Might patients with HLA-B27 related diseases benefit from antiandrogenic treatment?

Authors:  W H James
Journal:  Ann Rheum Dis       Date:  1995-06       Impact factor: 19.103

3.  Ovarian reserve in patients with ankylosing spondylitis.

Authors:  Pınar Yalçın Bahat; Pınar Kadiroğulları; Nura Fitnat Topbas Selcuki; Burak Yücel; Kübra Çakmak; Eda Üreyen Özdemir
Journal:  Arch Gynecol Obstet       Date:  2020-10-08       Impact factor: 2.344

4.  Somatosensory evoked potential findings in ankylosing spondylitis.

Authors:  Muharrem Cidem; Zerrin Sahin; Teoman Aydin; Fikret Aysal
Journal:  Eurasian J Med       Date:  2014-02

5.  Hypothalamic-pituitary-adrenal axis function in ankylosing spondylitis.

Authors:  R Imrich; J Rovensky; M Zlnay; Z Radikova; L Macho; M Vigas; J Koska
Journal:  Ann Rheum Dis       Date:  2004-06       Impact factor: 19.103

6.  Can the Second to Fourth Digit Ratio (2D : 4D) Be a Marker to Determine Ankylosing Spondylitis Disease Activity?

Authors:  Sevcan Uğur; Hasan Fatih Çay; İlhan Sezer; Cahit Kaçar
Journal:  Dis Markers       Date:  2019-02-11       Impact factor: 3.434

7.  Estrogen attenuates the spondyloarthritis manifestations of the SKG arthritis model.

Authors:  Hyemin Jeong; Eun-Kyung Bae; Hunnyun Kim; Yeong Hee Eun; In Young Kim; Hyungjin Kim; Jaejoon Lee; Chan Hong Jeon; Eun-Mi Koh; Hoon-Suk Cha
Journal:  Arthritis Res Ther       Date:  2017-09-07       Impact factor: 5.156

8.  Ankylosing spondylitis: etiology, pathogenesis, and treatments.

Authors:  Xu Cao; Xisheng Weng; Wei Zhu; Xuxia He; Kaiyuan Cheng; Linjie Zhang; Di Chen; Xiao Wang; Guixing Qiu
Journal:  Bone Res       Date:  2019-08-05       Impact factor: 13.567

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.